GRID/CPCA: A New Computational Tool To Design Selective Ligands
- 25 July 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (16) , 3033-3044
- https://doi.org/10.1021/jm000934y
Abstract
We present a computational procedure aimed at understanding enzyme selectivity and guiding the design of drugs with respect to selectivity. It starts from a set of 3D structures of the target proteins characterized by the program GRID. In the multivariate description proposed, the variables are organized and scaled in a different way than previously published methodologies. Then, consensus principal component analysis (CPCA) is used to analyze the GRID descriptors, allowing the straightforward identification of possible modifications in the ligand to improve its selectivity toward a chosen target. As an important new feature the computational method is able to work with more than two target proteins and with several 3D structures for each protein. Additionally, the use of a ‘cutout tool' allows to focus on the important regions around the active site. The method is validated for a total number of nine structures of the three homologous serine proteases thrombin, trypsin, and factor Xa. The regions identified by the method as being important for selectivity are in excellent agreement with available experimental data and inhibitor structure−activity relationships.Keywords
This publication has 38 references indexed in Scilit:
- Design of Benzamidine-Type Inhibitors of Factor XaJournal of Medicinal Chemistry, 1998
- Factor Xa inhibitors by classical and combinatorial chemistryDrug Discovery Today, 1998
- X-ray Structure of Active Site-inhibited Clotting Factor XaPublished by Elsevier ,1996
- Hierarchical multiblock PLS and PC models for easier model interpretation and as an alternative to variable selectionJournal of Chemometrics, 1996
- Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombinFEBS Letters, 1995
- A search for specificity in DNA-drug interactionsJournal of Molecular Graphics, 1994
- A Novel Factor Xa Inhibitor: Structure-Activity Relationships and Selectivity between Factor Xa and ThrombinBiochemical and Biophysical Research Communications, 1993
- Receptor subtypes or species homologues: relevance to drug discoveryTrends in Pharmacological Sciences, 1993
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991